I. N. Olver

Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma

Alan S. Coates, David Thomson, Grc McLeod et al. · European Journal of Cancer · 1993 · 135 citations

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

MR Stockler, Michael Jones, D. B. Thomson et al. · The Lancet · 2001 · 125 citations

Surgical Oncology, Oncology, Good-prognosis Germ-cell Tumours +9

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial

Elaine Beller, Martin Tattersall, Thomas Lumley et al. · Annals of Oncology · 1997 · 83 citations · Full text

Megestrol Acetate, Endocrine Oncology, Oncology +13

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.

Michael Millward, J. Bishop, Michael Friedländer et al. · Journal of Clinical Oncology · 1996 · 73 citations

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.

James F. Bishop, I. N. Olver, M. Wolf et al. · Journal of Clinical Oncology · 1984 · 57 citations

Medicine, Metronomic Therapy, Pharmacology +12